1. Home
  2. AUTL
  3. AUTL News

Latest Autolus Therapeutics plc (AUTL) News on July 26, 2024

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
AUTL

GlobeNewswire

13 hours ago

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
AUTL

GlobeNewswire

a month ago

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
AUTL

GlobeNewswire

2 months ago

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO

AUTL

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Autolus Therapeutics PLC Earnings Call

AUTL

MT Newswires

2 months ago

Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
AUTL

GlobeNewswire

2 months ago

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
AUTL

GlobeNewswire

2 months ago

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

AUTL

MT Newswires

2 months ago

Autolus Therapeutics Announces Delay of Q1 Earnings Release

Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
AUTL

GlobeNewswire

2 months ago

Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call

Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year
AUTL

Simply Wall St.

3 months ago

Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year

Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
AUTL

GlobeNewswire

3 months ago

Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
AUTL

GlobeNewswire

3 months ago

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
AUTL

GlobeNewswire

4 months ago

Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Autolus Therapeutics Announces Changes to its Board of Directors
AUTL

GlobeNewswire

4 months ago

Autolus Therapeutics Announces Changes to its Board of Directors

AUTL

Thomson Reuters StreetEvents

4 months ago

Q4 2023 BioNTech SE Earnings Call

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
AUTL

Insider Monkey

4 months ago

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript

Autolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
AUTL

Simply Wall St.

4 months ago

Autolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations

AUTL

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Autolus Therapeutics PLC Earnings Call

AUTL

GuruFocus.com

4 months ago

Autolus Therapeutics PLC Reports Full Year 2023 Financial Results

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
AUTL

GlobeNewswire

4 months ago

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
AUTL

GlobeNewswire

5 months ago

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site

Autolus Therapeutics announces publication in Blood Cancer Journal
AUTL

GlobeNewswire

5 months ago

Autolus Therapeutics announces publication in Blood Cancer Journal

Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
AUTL

GlobeNewswire

5 months ago

Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024

Autolus Therapeutics announces publication in Nature Communications
AUTL

GlobeNewswire

5 months ago

Autolus Therapeutics announces publication in Nature Communications

Autolus Therapeutics plc's (NASDAQ:AUTL) institutional investors lost 8.1% last week but have benefitted from longer-term gains
AUTL

Simply Wall St.

5 months ago

Autolus Therapeutics plc's (NASDAQ:AUTL) institutional investors lost 8.1% last week but have benefitted from longer-term gains

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?
AUTL

Zacks

5 months ago

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
AUTL

Zacks

5 months ago

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?

Autolus Announces Pricing of Underwritten Offering
AUTL

GlobeNewswire

6 months ago

Autolus Announces Pricing of Underwritten Offering

BioNTech partners with Autolus to boost cell therapy manufacturing
AUTL

BioPharma Dive

6 months ago

BioNTech partners with Autolus to boost cell therapy manufacturing

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
AUTL

GlobeNewswire

6 months ago

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains?
AUTL

Zacks

6 months ago

2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains?

JetBlue's (JBLU) Q4 Loss Narrower Than Expected, Q1 View Weak
AUTL

Zacks

6 months ago

JetBlue's (JBLU) Q4 Loss Narrower Than Expected, Q1 View Weak

Why Medical Properties Trust Stock Tumbled on Tuesday
AUTL

Motley Fool

6 months ago

Why Medical Properties Trust Stock Tumbled on Tuesday

Has Fastenal Company's (NASDAQ:FAST) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
AUTL

Simply Wall St.

6 months ago

Has Fastenal Company's (NASDAQ:FAST) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Varonis Extends Data Security Posture Management Coverage to Snowflake
AUTL

GlobeNewswire

6 months ago

Varonis Extends Data Security Posture Management Coverage to Snowflake

Trustmark (TRMK) Q4 Earnings and Revenues Top Estimates
AUTL

Zacks

6 months ago

Trustmark (TRMK) Q4 Earnings and Revenues Top Estimates

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade
AUTL

Zacks

6 months ago

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why
AUTL

Zacks

6 months ago

Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why

Autolus Therapeutics announces publication in ACS Chemical Biology
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics announces publication in ACS Chemical Biology

Beal Bank Provides $637.5 million of $885.0 million in New Debt to ProFrac Holding Corp (NASDAQ: ACDC) and its Subsidiaries
AUTL

PR Newswire

6 months ago

Beal Bank Provides $637.5 million of $885.0 million in New Debt to ProFrac Holding Corp (NASDAQ: ACDC) and its Subsidiaries

Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)
AUTL

GlobeNewswire

6 months ago

Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)

Should You Hold Digital Realty (DLR) Stock in Your Portfolio?
AUTL

Zacks

6 months ago

Should You Hold Digital Realty (DLR) Stock in Your Portfolio?

JinkoSolar Wins the Solar Power World 2023 Leadership in Solar Energy Award
AUTL

PR Newswire

6 months ago

JinkoSolar Wins the Solar Power World 2023 Leadership in Solar Energy Award

M&A Watch: 3 Tech Stocks With ‘Takeover Target’ Potential
AUTL

InvestorPlace

6 months ago

M&A Watch: 3 Tech Stocks With ‘Takeover Target’ Potential

NETSTREIT Corp. Announces Closing of Forward Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
AUTL

Business Wire

6 months ago

NETSTREIT Corp. Announces Closing of Forward Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

5 Retail REITs With The Best Relative Strength
AUTL

Benzinga

6 months ago

5 Retail REITs With The Best Relative Strength

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?
AUTL

Benzinga

6 months ago

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Is Now The Time To Look At Buying Gibraltar Industries, Inc. (NASDAQ:ROCK)?
AUTL

Simply Wall St.

6 months ago

Is Now The Time To Look At Buying Gibraltar Industries, Inc. (NASDAQ:ROCK)?

We're Not Very Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Rate
AUTL

Simply Wall St.

7 months ago

We're Not Very Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Rate

Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors

Here is Why Growth Investors Should Buy Murphy USA (MUSA) Now
AUTL

Zacks

7 months ago

Here is Why Growth Investors Should Buy Murphy USA (MUSA) Now

Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering
AUTL

Investor's Business Daily

7 months ago

Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering

Global Net Lease, Inc. Announces Common Stock Dividend for the First Quarter 2024
AUTL

GlobeNewswire

7 months ago

Global Net Lease, Inc. Announces Common Stock Dividend for the First Quarter 2024

Should You Think About Buying Oxford Industries, Inc. (NYSE:OXM) Now?
AUTL

Simply Wall St.

7 months ago

Should You Think About Buying Oxford Industries, Inc. (NYSE:OXM) Now?

3 Stocks That Could Be Monster Winners in 2024
AUTL

Motley Fool

7 months ago

3 Stocks That Could Be Monster Winners in 2024

Gold nears $2100, biotech stocks on the move: Trending tickers
AUTL

Yahoo Finance Video

7 months ago

Gold nears $2100, biotech stocks on the move: Trending tickers

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
AUTL

GlobeNewswire

7 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day
AUTL

Zacks

7 months ago

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024
AUTL

Zacks

7 months ago

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

Autolus Therapeutics Announces Changes to its Board of Directors
AUTL

GlobeNewswire

7 months ago

Autolus Therapeutics Announces Changes to its Board of Directors

Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
AUTL

PR Newswire

7 months ago

Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

12 Most Promising Cancer Stocks According to Analysts
AUTL

Insider Monkey

7 months ago

12 Most Promising Cancer Stocks According to Analysts

Insider Sell Alert: Director Bennett Lebow Sells 171,054 Shares of Vector Group Ltd (VGR)
AUTL

GuruFocus.com

7 months ago

Insider Sell Alert: Director Bennett Lebow Sells 171,054 Shares of Vector Group Ltd (VGR)

Sylvamo Announces Dividend
AUTL

Business Wire

7 months ago

Sylvamo Announces Dividend

Helios Technologies Extends History of Quarterly Dividends With 108th Consecutive Cash Dividend
AUTL

Business Wire

7 months ago

Helios Technologies Extends History of Quarterly Dividends With 108th Consecutive Cash Dividend

Insider Sell Alert: CFO Tania Secor Offloads Shares of Integral Ad Science Holding Corp
AUTL

GuruFocus.com

7 months ago

Insider Sell Alert: CFO Tania Secor Offloads Shares of Integral Ad Science Holding Corp

MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
AUTL

Business Wire

8 months ago

MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
AUTL

GlobeNewswire

8 months ago

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023

Sportradar Appoints Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance
AUTL

GlobeNewswire

8 months ago

Sportradar Appoints Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance

First Bank and NCHBA Partner to Bring Copies of The House That She Built Book to Elementary Students Throughout North Carolina
AUTL

PR Newswire

8 months ago

First Bank and NCHBA Partner to Bring Copies of The House That She Built Book to Elementary Students Throughout North Carolina

‘Bright Spots’ Could Lift These 2 Hotel REIT Stocks Higher, Says Oppenheimer
AUTL

TipRanks

8 months ago

‘Bright Spots’ Could Lift These 2 Hotel REIT Stocks Higher, Says Oppenheimer

11 Best Young Stocks to Buy and Hold For 20 Years
AUTL

Insider Monkey

8 months ago

11 Best Young Stocks to Buy and Hold For 20 Years

Taboola Announces New, Five-Year Deal with NBCUniversal News Group, Including NBC News, CNBC, MSNBC and TODAY
AUTL

GlobeNewswire

8 months ago

Taboola Announces New, Five-Year Deal with NBCUniversal News Group, Including NBC News, CNBC, MSNBC and TODAY

Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference
AUTL

GlobeNewswire

8 months ago

Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference

Wall Street Analysts Believe Verona Pharma PLC American Depositary Share (VRNA) Could Rally 135.87%: Here's is How to Trade
AUTL

Zacks

8 months ago

Wall Street Analysts Believe Verona Pharma PLC American Depositary Share (VRNA) Could Rally 135.87%: Here's is How to Trade

Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award
AUTL

GlobeNewswire

8 months ago

Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) Q3 2023 Earnings Call Transcript
AUTL

Insider Monkey

9 months ago

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) Q3 2023 Earnings Call Transcript

Xenia Hotels & Resorts, Inc. (NYSE:XHR) Q3 2023 Earnings Call Transcript
AUTL

Insider Monkey

9 months ago

Xenia Hotels & Resorts, Inc. (NYSE:XHR) Q3 2023 Earnings Call Transcript

Is Now The Time To Put United States Lime & Minerals (NASDAQ:USLM) On Your Watchlist?
AUTL

Simply Wall St.

9 months ago

Is Now The Time To Put United States Lime & Minerals (NASDAQ:USLM) On Your Watchlist?

Share on Social Networks: